Skip to main content
. 2022 Oct 29;10(11):2754. doi: 10.3390/biomedicines10112754

Figure 2.

Figure 2

Overview of the main pathophysiological pathways in OSA-related dyslipidaemia. The red arrows show the altered pathways and dysregulations. CM—chylomicron; FFA—free fatty acid; HDL—high-density lipoprotein; HIF-1α—hypoxia-inducible factor 1 alpha; IR—insulin resistance; LDL—low-density lipoprotein; LDLR—low-density lipoprotein receptor; LpL—lipoprotein lipase; LRP-1—LDL receptor-related protein 1; oxLDL—oxidised-LDL; SCD-1—stearoyl-coenzyme A desaturase 1; SREBP-1—sterol regulatory element-binding protein 1; TG—triglyceride; VLDL—very-low-density lipoprotein. For description and references, please see the text.